4/4/2013

Researchers at the Duke University School of Medicine tracked the evolution of a broadly neutralizing antibody that recognizes different HIV strains, which could lead to the design of a vaccine. Broadly neutralizing antibodies are typically produced after the patient's HIV population has diversified, researchers reported online in Nature.

Related Summaries